CO951 : Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores, to be replaced by CO952
Microarray Panel Colon adenocarcinoma tissue microarray, duplicated cores, 30 cancer and 8 of which has matched normal adjacent tissue and 10 cases of matched metastasis, with follow-up data 2 cores per case
Cores 95

Cases 30
Layout SBC
Row number 8
Column number 12
Core Diameter(mm) 1.5
Thickness(┬Ám) 5
IHC1 Anti-Cytokeratin (CK) confirmed
Tissue Array Type Paraffin
Genera Homo
Applications Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Slide Label: US Biomax, Inc. Tissue Array
123456789101112
ARecRecSigSigAscAscTraTraSigSigAscAsc
BSigSigDesDesRecRecAscAscDesDesCecCec
CSigSigAscAscAscAscTraTraAscAscSigSig
DAscAscSigSigSigSigSigSigRecRecSigSig
ERecRecSigSigSigSigCecCecTraTraAscAsc
FLunLunLymLymOvaOvaLymLymLymLymLymLym
GOvaOvaLunLunOvaOvaLymLymSigSigAscAsc
HAscAscRecRecDesDesAscAscSigSigSigSig
Legend: Asc - Ascending colon, Cec - Cecum, Des - Descending colon, Lun - Lung, Lym - Lymph node, Ova - Ovary, Rec - Rectum, Sig - Sigmoid colon, Tra - Transverse colon

- , - , - , - , -

Pos. No.AgeSexOrganPathology diagnosisTNMGradeStageType Months*pTNM Image
A1 1 M Rectum adenocarcinoma, moderately differentiated IIIB . T4N1M1
A2 2 M Rectum adenocarcinoma, moderately differentiated IIIB . T4N1M1
A3 3 F Sigmoid colon adenocarcinoma, well differentiated IIIC . T3N2M0
A4 4 F Sigmoid colon adenocarcinoma, well differentiated IIIC . T3N2M0
A5 5 M Ascending colon adenocarcinoma, moderately differentiated IIIB . T3N1M0
A6 6 M Ascending colon adenocarcinoma, moderately differentiated IIIB . T3N1M0
A7 7 M Transverse colon adenocarcinoma, moderately differentiated IIIC . T3N2M1
A8 8 M Transverse colon adenocarcinoma, moderately differentiated IIIC . T3N2M1
A9 9 F Sigmoid colon adenocarcinoma, well differentiated IIA . T3N0M0
A10 10 F Sigmoid colon adenocarcinoma, well differentiated IIA . T3N0M0
A11 11 M Ascending colon adenocarcinoma, moderately differentiated IIA . T3N0M0
A12 12 M Ascending colon adenocarcinoma, moderately differentiated IIA . T3N0M0
B1 13 F Sigmoid colon adenocarcinoma, well differentiated IIIB . T3N1M0
B2 14 F Sigmoid colon adenocarcinoma, well differentiated IIIB . T3N1M0
B3 15 F Descending colon adenocarcinoma, well differentiated IV . T4N1M1
B4 16 F Descending colon adenocarcinoma, well differentiated IV . T4N1M1
B5 17 M Rectum adenocarcinoma, well differentiated IIIB . T3N1M0
B6 18 M Rectum adenocarcinoma, well differentiated IIIB . T3N1M0
B7 19 M Ascending colon adenocarcinoma, well differentiated IIIB . T3N1M0
B8 20 M Ascending colon adenocarcinoma, well differentiated IIIB . T3N1M0
B9 21 F Descending colon adenocarcinoma, moderately differentiated IIIB . T3N1M0
B10 22 F Descending colon adenocarcinoma, moderately differentiated IIIB . T3N1M0
B11 23 M Cecum adenocarcinoma, moderately differentiated IIIB . T3N1M0
B12 24 M Cecum adenocarcinoma, moderately differentiated IIIB . T3N1M0
C1 25 M Sigmoid colon adenocarcinoma, moderately differentiated IIIB . T3N1M0
C2 26 M Sigmoid colon adenocarcinoma, moderately differentiated IIIB . T3N1M0
C3 27 F Ascending colon adenocarcinoma, poorly differentiated IIIC . T3N2M1
C4 28 F Ascending colon adenocarcinoma, poorly differentiated IIIC . T3N2M1
C5 29 M Ascending colon adenocarcinoma, moderately differentiated IIA . T3N0M0
C6 30 M Ascending colon adenocarcinoma, moderately differentiated IIA . T3N0M0
C7 31 M Transverse colon adenocarcinoma, moderately differentiated IIIC . T3N2M1
C8 32 M Transverse colon adenocarcinoma, moderately differentiated IIIC . T3N2M1
C9 33 F Ascending colon adenocarcinoma, moderately differentiated IIIC . T3N2M0
C10 34 F Ascending colon adenocarcinoma, moderately differentiated IIIC . T3N2M0
C11 35 M Sigmoid colon adenocarcinoma, moderately differentiated IV . T3N1M1
C12 36 M Sigmoid colon adenocarcinoma, moderately differentiated IV . T3N1M1
D1 37 M Ascending colon adenocarcinoma, moderately differentiated IIA . T3N0M0
D2 38 M Ascending colon adenocarcinoma, moderately differentiated IIA . T3N0M0
D3 39 M Sigmoid colon adenocarcinoma, moderately differentiated IV . T3N2M1
D4 40 M Sigmoid colon adenocarcinoma, moderately differentiated IV . T3N2M1
D5 41 M Sigmoid colon adenocarcinoma, moderately differentiated IIA . T3N0M0
D6 42 M Sigmoid colon adenocarcinoma, moderately differentiated IIA . T3N0M0
D7 43 F Sigmoid colon adenocarcinoma, moderately differentiated IV . T3N2M1
D8 44 F Sigmoid colon adenocarcinoma, moderately differentiated IV . T3N2M1
D9 45 F Rectum adenocarcinoma, well differentiated IIIB . T3N1M0
D10 46 F Rectum adenocarcinoma, well differentiated IIIB . T3N1M0
D11 47 F Sigmoid colon adenocarcinoma, well differentiated IV . T4N2M1
D12 48 F Sigmoid colon adenocarcinoma, well differentiated IV . T4N2M1
E1 49 M Rectum adenocarcinoma, moderately differentiated IIIC . T4N2M1
E2 50 M Rectum adenocarcinoma, moderately differentiated IIIC . T4N2M1
E3 51 F Sigmoid colon adenocarcinoma, moderately differentiated IV . T4N1M1
E4 52 F Sigmoid colon adenocarcinoma, moderately differentiated IV . T4N1M1
E5 53 M Sigmoid colon adenocarcinoma, moderately differentiated IIIB . T3N1M0
E6 54 M Sigmoid colon adenocarcinoma, moderately differentiated IIIB . T3N1M0
E7 55 F Cecum Mucinous adenocarcinoma IIIC . T3N2M1
E8 56 F Cecum Mucinous adenocarcinoma IIIC . T3N2M1
E9 57 M Transverse colon Mucinous adenocarcinoma IIA . T3N0M0
E10 58 M Transverse colon Mucinous adenocarcinoma IIA . T3N0M0
E11 59 F Ascending colon Mucinous adenocarcinoma IIA . T3N0M0
E12 60 F Ascending colon Mucinous adenocarcinoma IIA . T3N0M0
F1 61 M Lung metastatic adenocarcinoma from #1 . 42 .
F2 62 M Lung metastatic adenocarcinoma from #1 . 42 .
F3 63 M Lymph node metastatic carcinoma from #4 . 0 .
F4 64 M Lymph node metastatic carcinoma from #4 . 0 .
F5 65 F Ovary metastatic adenocarcinoma from #8 . 0 .
F6 66 F Ovary metastatic adenocarcinoma from #8 . 0 .
F7 67 F Lymph node metastatic carcinoma from #14 . 0 .
F8 68 F Lymph node metastatic carcinoma from #14 . 0 .
F9 69 M Lymph node metastatic carcinoma from #16 . 0 .
F10 70 M Lymph node metastatic carcinoma from #16 . 0 .
F11 71 M Lymph node metastatic carcinoma from #20 . 0 .
F12 72 M Lymph node metastatic carcinoma from #20 . 0 .
G1 73 F Ovary metastatic adenocarcinoma from #24 . 0 .
G2 74 F Ovary metastatic adenocarcinoma from #24 . 0 .
G3 75 M Lung metastatic adenocarcinoma from #25 . 17 .
G4 76 M Lung metastatic adenocarcinoma from #25 . 17 .
G5 77 F Ovary metastatic adenocarcinoma from #26 . 0 .
G6 78 F Ovary metastatic adenocarcinoma from #26 . 0 .
G7 79 F Lymph node metastatic carcinoma from #28 . 0 .
G8 80 F Lymph node metastatic carcinoma from #28 . 0 .
G9 81 F Sigmoid colon normal colon (match of #2) . . .
G10 82 F Sigmoid colon normal colon (match of #2) . . .
G11 83 M Ascending colon normal colon (match of #3) . . .
G12 84 M Ascending colon normal colon (match of #3) . . .
H1 85 M Ascending colon normal colon (match of #6) . . .
H2 86 M Ascending colon normal colon (match of #6) . . .
H3 87 M Rectum normal colon (match of #9) . . .
H4 88 M Rectum normal colon (match of #9) . . .
H5 89 F Descending colon normal colon (match of #11) . . .
H6 90 F Descending colon normal colon (match of #11) . . .
H7 91 F Ascending colon normal colon (match of #17) . . .
H8 92 F Ascending colon normal colon (match of #17) . . .
H9 93 M Sigmoid colon normal colon (match of #18) . . .
H10 94 M Sigmoid colon normal colon (match of #18) . . .
H11 95 M Sigmoid colon normal colon (match of #21) . . .
H12 96 M Sigmoid colon normal colon (match of #21) . . .

No.Follow-up monthsFollow-up resultCause of deathRemark
1 67 dead cancer .
2 67 dead cancer .
3 130 alive . .
4 130 alive . .
5 30 dead cancer .
6 30 dead cancer .
7 2 dead cancer .
8 2 dead cancer .
9 125 alive . .
10 125 alive . .
11 125 alive . .
12 125 alive . .
13 125 alive . .
14 125 alive . .
15 0 lost . .
16 0 lost . .
17 0 dead cancer .
18 0 dead cancer .
19 124 alive . .
20 124 alive . .
21 124 alive . .
22 124 alive . .
23 123 alive . .
24 123 alive . .
25 123 alive . .
26 123 alive . .
27 2 dead cancer .
28 2 dead cancer .
29 35 dead cancer .
30 35 dead cancer .
31 122 alive . .
32 122 alive . .
33 122 alive . .
34 122 alive . .
35 57 dead cancer .
36 57 dead cancer .
37 122 alive . .
38 122 alive . .
39 3 dead cancer .
40 3 dead cancer .
41 121 alive . .
42 121 alive . .
43 11 dead cancer .
44 11 dead cancer .
45 121 alive . .
46 121 alive . .
47 12 dead cancer .
48 12 dead cancer .
49 105 alive . .
50 105 alive . .
51 25 dead cancer .
52 25 dead cancer .
53 60 dead cancer .
54 60 dead cancer .
55 127 alive . .
56 127 alive . .
57 124 alive . .
58 124 alive . .
59 122 alive . .
60 122 alive . .
61 22 dead cancer .
62 22 dead cancer .
63 2 dead cancer .
64 2 dead cancer .
65 0 lost . .
66 0 lost . .
67 2 dead cancer .
68 2 dead cancer .
69 122 alive . .
70 122 alive . .
71 3 dead cancer .
72 3 dead cancer .
73 12 dead cancer .
74 12 dead cancer .
75 88 alive . .
76 88 alive . .
77 25 dead cancer .
78 25 dead cancer .
79 127 alive . .
80 127 alive . .
81 . . . .
82 . . . .
83 . . . .
84 . . . .
85 . . . .
86 . . . .
87 . . . .
88 . . . .
89 . . . .
90 . . . .
91 . . . .
92 . . . .
93 . . . .
94 . . . .
95 . . . .
96 . . . .

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
 

Write a review

Please login or register to review
  • $395.00

Tags: Duplicate cores per case, Metastasis, With normal control, With adjacent normal, With normal control (), Stage (TNM), Survival data